Crossmark

Synergistic regulation of TGF-β1/Smad2/3 signaling and inflammatory pathways via SA/NAC-based nanoplatforms: a novel strategy to enhance anti-fibrotic therapeutic outcomes in idiopathic pulmonary fibrosis

Crossref DOI link: https://doi.org/10.1186/s12951-026-04071-4

Published Online: 2026-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Ce

Yuan, Yichao

Bao, Yaqing

Ni, Yeling

Chen, Nan

Piao, Jigang

Wang, Lu

Zhu, Zhihong
Funding

Funding for this research was provided by:

National Natural Science Foundation of Zhejiang Province (LQ20H270014)

Zhejiang Provincial Natural Science Foundation of China (LY23H280010)

Research Project of Zhejiang Chinese Medical University (2023JKZKTS23)
License Information

Text and Data Mining valid from 2026-01-25

Version of Record valid from 2026-02-17
More Information

Article History

Received: 28 October 2025

Accepted: 16 January 2026

First Online: 25 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below